KNC Laboratories Co., Ltd.
|KNC Laboratories Co., Ltd. Patent applications|
|Patent application number||Title||Published|
|20150191571||POLYAMIDE COMPOUND AND PHARMACEUTICAL COMPOSITION FOR TREATING MITOCHONDRIAL GENETIC DISEASE - The object of the present invention is to provide a fundamental therapy to mitochondrial genetic diseases caused by mutation of the mitochondrial (mt)DNA, and a pharmaceutical composition used for the same.||07-09-2015|
|20140194412||THIOXOTHIAZOLIDINE DERIVATIVE HAVING RAS FUNCTION INHIBITORY EFFECT - The present invention provides an anticancer drug having a Ras function inhibitory action.||07-10-2014|
|20110046360||ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR - Oligonucleotides having a nucleotide sequence complementary to nucleotide numbers such as 2571-2607, 2578-2592, 2571-2592, 2573-2592, 2578-2596, 2578-2601 or 2575-2592 of the dystrophin cDNA (Gene Bank accession No. NM_004006.1) and therapeutic agents for muscular dystrophy comprising such oligonucleotides.||02-24-2011|